Effect of Agave Inulin on Constipation and Quality of Life in Peritoneal Dialysis Patients.

Launched by NIN INSTITUTE · Dec 16, 2024

Keywords

ClinConnect Summary

Constipation affects a large part of the population with Chronic Kidney Disease (CKD), and in Peritoneal Dialysis (PD) it is the most common symptom derived from multiple factors, including dietary restrictions causing insufficient fiber intake, water restriction, drug consumption and the change in the intestinal microbiota derived from uremic toxins during this stage, leading to a poor quality of life in the patient and consequently an alteration in the patient\'s nutritional status. In turn, constipation has become a risk factor in the development of cardiovascular diseases, of which ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Over 18 years
• • Beginning of peritoneal dialysis in the last month
• • Constipation
• • Medical follow-up by nephrology every month
• • Without Irritable Bowel Syndrome
• • No frailty criteria
• Exclusion Criteria:
• • Patients who don\'t to take the supplement
• • Patients with diarrhea
• • Patients with a diagnosed intestinal disorder
• • Allergic to any ingredient of the supplement.
• • Previous probiotic and/or prebiotic supplementation in the last month
• • Diagnosis of comorbidities such as cancer, decompensated heart failure, decompensated pulmonary disease, decompensated liver disease, HIV, infection present within the last 3 months (chronic and/or acute), stroke and malabsorption syndrome.
• • Hospitalizations within the last month for peritonitis
• • Pregnant women
• • Patients with psychiatric illnesses